Single Cell Analysis Revealed That the Response to Cyclophosphamide Therapy Is Regulated By B Cells in Systemic Sclerosis-Associated Interstitial Lung Disease

被引：0

作者：

Ebata, Satoshi ^{[1
]}

Yoshizaki, Ayumi ^{[2
]}

Fukasawa, Takemichi ^{[1
]}

Nakamura, Kouki ^{[1
]}

Hirakawa, Maiko ^{[1
]}

Yamashita, Takashi ^{[1
]}

Miura, Shunsuke ^{[3
]}

Saigusa, Ryosuke ^{[1
]}

Hirabayashi, Megumi ^{[1
]}

Yoshizaki, Asako ^{[1
]}

Akamata, Kaname ^{[1
]}

Asano, Yoshihide ^{[4
]}

Kazoe, Yutaka ^{[5
]}

Mawatari, Kazuma ^{[5
]}

Kitamori, Takehiko ^{[5
]}

Sato, Shinichi ^{[6
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dermatol, Tokyo, Japan

[2] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo, Japan

[3] Univ Tokyo, Grad Sch Med, Tokyo, Japan

[4] Univ Tokyo, Grad Sch Med, Appl Chem, Tokyo, Japan

[5] Univ Tokyo, Grad Sch Engn, Appl Chem, Tokyo, Japan

[6] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[21] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
Cuomo, G.
Di Vico, C.
Perretta, D.
Iandoli, C.
Ciaburri, R.
Adamo, P.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
[22] INCREASE OF ENDOTHELIAL PROGENITOR CELLS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
Pulito-Cueto, V.
Martinez, S. Remuzgo
Genre, F.
Atienza-Mateo, B.
Mora-Cuesta, V. M.
Iturbe-Fernandez, D.
Lera-Gomez, L.
Perez-Fernandez, R.
Prieto-Pena, D.
Portilla, V.
Blanco, R.
Corrales, A.
Cifrian-Martinez, J. M.
Lopez-Mejias, R.
Gonzalez-Gay, M. A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1076 - 1076
[23] Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Chung, Jonathan H.
Walker, Christopher M.
Hobbs, Stephen
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : na
[24] Effectiveness and Safety of Tacrolimus Following Intravenous Cyclophosphamide Pulse Therapy As the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease
Ichimura, Yuki
Kawaguchi, Yasushi
Takagi, Kae
Tochimoto, Akiko
Higuchi, Tomoaki
Katsumata, Yasuhiro
Yamanaka, Hisashi
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[25] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
Distler, Oliver
Gahlemann, Martina
Maher, Toby M.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
[26] Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
Ma, Angela
Montesi, Sydney B.
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)
[27] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
Athanasios Koutroumpas
Athanasios Ziogas
Ioannis Alexiou
Georgia Barouta
Lazaros I. Sakkas
Clinical Rheumatology, 2010, 29 : 1167 - 1168
[28] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
Koutroumpas, Athanasios
Ziogas, Athanasios
Alexiou, Ioannis
Barouta, Georgia
Sakkas, Lazaros I.
CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
[29] Responses to exercise in systemic sclerosis-associated interstitial lung disease
Donnelly, Ronan P.
Smyth, Anita E.
Mullan, Charles
Riley, Marshall S.
Nicholls, D. Paul
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) : 253 - 262
[30] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
Yamasaki, Yoshioki
Kuwana, Masataka
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560

← 1 2 3 4 5 →